Successful treatment of multidrug resistant Acinetobacter baumannii meningitis.
BACKGROUND
Acinetobacter baumannii is a major cause of nosocomial infections in many hospitals and appears to have a propensity for developing multiple antimicrobial resistance rapidly.


METHODS
We report two cases with post-surgical meningitis due to multidrug resistant A. baumannii which were successfully treated with high-dose intravenous meropenem therapy.


CONCLUSIONS
Multidrug resistant Acinetobacter spp. in intensive care units are a growing concern. High-dose meropenem is used in the treatment of these infections.
Saçar
Suzan
S
Pamukkale University Hospital, Infectious Diseases and Clinical Microbiology Department, Denzili, Turkey. suzansacar@yahoo.com
Turgut
H
H
Cenger
D Hirçin
DH
Coşkun
E
E
Asan
A
A
Kaleli
I
I
D000151:Acinetobacter Infections / Q000188:drug therapy*; D040981:Acinetobacter baumannii / Q000187:drug effects*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D024901:Drug Resistance, Multiple, Bacterial / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D016920:Meningitis, Bacterial / Q000188:drug therapy* / Q000382:microbiology; D000077731:Meropenem; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D013845:Thienamycins / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D013845:Thienamycins; D000077731:Meropenem